Granite Point Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-123,176
Closed -$775K 123
2019
Q1
$775K Buy
123,176
+90,000
+271% +$631K 0.08% 74
2018
Q4
$215K Sell
33,176
-57,326
-63% -$438K 0.04% 87
2018
Q3
$751K Sell
90,502
-5,000
-5% -$38K 0.05% 91
2018
Q2
$595K Sell
95,502
-59,900
-39% -$381K 0.05% 97
2018
Q1
$1.06M Sell
155,402
-232,598
-60% -$1.48M 0.1% 57
2017
Q4
$2.55M Sell
388,000
-70,302
-15% -$429K 0.25% 22
2017
Q3
$2.55M Buy
458,302
+36,998
+9% +$250K 0.54% 20
2017
Q2
$3.25M Buy
421,304
+317,804
+307% +$2.69M 0.8% 19
2017
Q1
$933K Buy
+103,500
New +$1.08M 0.28% 49

Other funds holding NPTN

Granite Point Capital Management's NPTN Position: Q2 2019 in Review

Granite Point Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2019, closing a stake of 123,176 shares — an estimated $775K sold.

Granite Point Capital Management first reported a position in NPTN in Q1 2017 and held it in 9 quarters. The position peaked at $3.25M in Q2 2017. 113 funds tracked by Wall St. Rank hold NPTN as of Q2 2019.

  • Granite Point Capital Management reported no remaining NEOPHOTONICS CORP position as of Q2 2019 after selling out during the quarter.
  • Granite Point Capital Management sold 123,176 NEOPHOTONICS CORP shares in Q2 2019, an estimated $775K.
  • Granite Point Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2017 and held it in 9 quarters.
  • Granite Point Capital Management's NEOPHOTONICS CORP position peaked at $3.25M in Q2 2017.
  • 113 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2019.

Based on Granite Point Capital Management's 13F filing for Q2 2019, filed 29 Jul 2019.